WO2008092826A3 - Cistusextrakte - Google Patents

Cistusextrakte Download PDF

Info

Publication number
WO2008092826A3
WO2008092826A3 PCT/EP2008/050966 EP2008050966W WO2008092826A3 WO 2008092826 A3 WO2008092826 A3 WO 2008092826A3 EP 2008050966 W EP2008050966 W EP 2008050966W WO 2008092826 A3 WO2008092826 A3 WO 2008092826A3
Authority
WO
WIPO (PCT)
Prior art keywords
cistus
extracts
cistus extracts
bacterial
preventing
Prior art date
Application number
PCT/EP2008/050966
Other languages
English (en)
French (fr)
Other versions
WO2008092826A2 (de
Inventor
Detlef Schierstedt
Original Assignee
Krewel Meuselbach Gmbh
Detlef Schierstedt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krewel Meuselbach Gmbh, Detlef Schierstedt filed Critical Krewel Meuselbach Gmbh
Priority to US12/525,312 priority Critical patent/US20100062068A1/en
Priority to EP08708284A priority patent/EP2124979A2/de
Priority to JP2009547652A priority patent/JP2010517956A/ja
Publication of WO2008092826A2 publication Critical patent/WO2008092826A2/de
Publication of WO2008092826A3 publication Critical patent/WO2008092826A3/de
Priority to US13/449,816 priority patent/US8691294B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung betrifft die Verwendung eines Nasensprays aus Cistusextrakten zur Vorbeugung und/oder zur Behandlung von viralen und/oder bakteriellen Erkrankungen des Mund- und Rachenraums.
PCT/EP2008/050966 2007-02-02 2008-01-28 Cistusextrakte WO2008092826A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US12/525,312 US20100062068A1 (en) 2007-02-02 2008-01-28 Cistus extracts
EP08708284A EP2124979A2 (de) 2007-02-02 2008-01-28 Cistusextrakte
JP2009547652A JP2010517956A (ja) 2007-02-02 2008-01-28 シスタス抽出物（ＣｉｓｔｕｓＥｘｔｒａｃｔｓ）
US13/449,816 US8691294B2 (en) 2007-02-02 2012-04-18 Cistus extracts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007006122A DE102007006122A1 (de) 2007-02-02 2007-02-02 Cistusextrakte
DE102007006122.8 2007-02-02

Publications (2)

Publication Number Publication Date
WO2008092826A2 WO2008092826A2 (de) 2008-08-07
WO2008092826A3 true WO2008092826A3 (de) 2009-03-05

Family

ID=39587358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/050966 WO2008092826A2 (de) 2007-02-02 2008-01-28 Cistusextrakte

Country Status (6)

Country Link
US (2) US20100062068A1 (de)
EP (1) EP2124979A2 (de)
JP (1) JP2010517956A (de)
CN (1) CN101626776A (de)
DE (1) DE102007006122A1 (de)
WO (1) WO2008092826A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007006122A1 (de) 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
IT202100018035A1 (it) 2021-07-08 2023-01-08 St Farmochimico Fitoterapico Epo S R L Ed In Forma Abbreviata Epo S R L ASSOCIAZIONE ANTIBATTERICA SINERGICA DI ESTRATTI DI SCUTELLARIA LATERIFLORA E DI CISTUS x INCANUS
WO2024046653A1 (en) 2022-08-29 2024-03-07 Mycotech Pharma As Antiviral fungal extracts

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202005014459U1 (de) * 2005-09-13 2006-01-19 Pandalis, Georgios, Dr. Aerosol zur Vorbeugung und Behandlung der Influenza
EP1837029A1 (de) * 2006-03-24 2007-09-26 Georgios Pandalis Zusammensetzung zur Vorbeugung und Behandlung von Erkältungskrankheiten

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508282C1 (en) * 1993-05-17 2001-01-23 Tulin Silver Jeffrey Composition and method for treating acute or chronic rhinosinusitis
JP4097737B2 (ja) * 1997-04-07 2008-06-11 ユニチカ株式会社 鼻口腔用抗炎症散布剤
JPH11322582A (ja) * 1998-05-06 1999-11-24 Dot:Kk 経鼻吸収用鼻粘膜付着・滞留型キャリヤ
ATE226429T1 (de) * 1998-08-24 2002-11-15 Procter & Gamble Orale flüssige mucoadhäsive zusammensetzungen
JP2000217916A (ja) * 1999-01-01 2000-08-08 Masakazu Imai 人力・電力両用で作動する粒子選択性ネブライザ―とその製造法
JP2003512323A (ja) * 1999-10-19 2003-04-02 ザ、プロクター、エンド、ギャンブル、カンパニー ピログルタミン酸及び金属塩を含む抗菌組成物
US6664289B2 (en) * 2002-03-18 2003-12-16 Richard L. Hansen Nasal solution containing a broad spectrum microbicide and a method for its use
PL373033A1 (en) * 2002-06-20 2005-08-08 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
EP1556062B1 (de) * 2002-08-28 2009-12-23 Lupin Limited Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung
AT413078B (de) * 2002-10-10 2005-11-15 Gebro Pharma Gmbh Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
WO2006040680A1 (en) * 2004-10-15 2006-04-20 Pfizer Products Inc. Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline
WO2007031297A2 (en) * 2005-09-13 2007-03-22 Georgios Pandalis Use of cistus incanus extracts for the preparation of a medicament for the prevention and/or treatment of influenza
JP2009531342A (ja) * 2006-03-24 2009-09-03 ゲオルギオス パンダリス かぜの予防および治療用組成物
DE102007006122A1 (de) 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202005014459U1 (de) * 2005-09-13 2006-01-19 Pandalis, Georgios, Dr. Aerosol zur Vorbeugung und Behandlung der Influenza
EP1837029A1 (de) * 2006-03-24 2007-09-26 Georgios Pandalis Zusammensetzung zur Vorbeugung und Behandlung von Erkältungskrankheiten

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K.H. BAUER, K.-H. FRÖMMING, C. FÜHRER: "Pharmazeutische Technologie", 1991, GEORG THIEME VERLAG, STUTTGART, XP002505509 *

Also Published As

Publication number Publication date
JP2010517956A (ja) 2010-05-27
CN101626776A (zh) 2010-01-13
WO2008092826A2 (de) 2008-08-07
EP2124979A2 (de) 2009-12-02
US20120201866A1 (en) 2012-08-09
US20100062068A1 (en) 2010-03-11
US8691294B2 (en) 2014-04-08
DE102007006122A1 (de) 2008-08-07

Similar Documents

Publication Publication Date Title
ZA200901523B (en) Use of extracts for the treatment of viral disorders
HK1129594A1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
EP2114500B8 (de) Atemmaske
WO2008000512A3 (en) Method for identifying crmp modulators
EP2026723A4 (de) Nasenatemgeräte
EP2051760A4 (de) Verabreichung einer atemtherapie
EP2046430A4 (de) Verabreichung einer atemtherapie
EP2101855A4 (de) Verabreichung einer atemtherapie
EP2049035A4 (de) Systeme zur behandlung von nasengewebe
WO2011053825A3 (en) Compositions and methods for the treatment or prevention of mitochondrial diseases
HK1157637A1 (en) Aerosolized fosfomycin/tobramycin combination for the treatment of bacterial respiratory infections
EP1962869A4 (de) Behandlung von atemwegserkrankungen
GB0610790D0 (en) Therapeutic uses of tomato extracts
WO2007144778A3 (en) Herbal compositions for the prevention or treatment of a urinary tract infection
EP2207555A4 (de) Neue verbindungen zur behandlung oder linderung von ödem und anwendungsverfahren dafür
IL197783A0 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
PL2276505T3 (pl) Sprej do nosa lub krople do nosa do leczenia przeziębienia
WO2008092826A3 (de) Cistusextrakte
WO2007132355A3 (en) Compositions and methods for inhibiting viral adhesion
USD652518S1 (en) Nasal respirator
IL195096A (en) Use of aqueous solution of tobacco leaf extract to manufacture a drug for the treatment of tobacco dependence and kits containing it
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
WO2009074498A8 (en) Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate
ES2375436T8 (es) Administración intranasal o por inhalación de virosomas.
WO2007132438A3 (en) Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880003748.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08708284

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008708284

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2009547652

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12525312

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE